What is it?
Muscimol is a potent GABA-A receptor agonist from Amanita muscaria that works **fundamentally differently from psilocybin**—producing sedative rather than psychedelic effects. This GABAergic compound has gained significant attention since 2019 when microdosing protocols emerged.
**Critical distinction**: Unlike classical psychedelics (psilocybin, LSD) which act on serotonin 5-HT₂A receptors and cause neuronal excitation, muscimol binds directly to GABA-A receptors causing neuronal **inhibition**. Effects are sedative, dreamlike, and dissociative—not visual or emotionally intensified.
**The ibotenic acid problem**: Fresh or improperly prepared Amanita muscaria contains predominantly ibotenic acid (a neurotoxin used to create brain lesions in research) at a 9:1 ratio to muscimol. Proper decarboxylation through heat and acid is **non-negotiable** for safety.
🚨 Important Warnings
Please read all warnings carefully before use.
Fresh or improperly prepared Amanita muscaria contains predominantly neurotoxic ibotenic acid (9:1 ratio). Proper decarboxylation through acidic heat extraction (pH 2.5-3.0, 3+ hours) is ESSENTIAL. Air drying alone converts only 10-30%.
Risk of respiratory depression, especially when combined with other CNS depressants. NEVER combine with alcohol, benzodiazepines, opioids, GHB, or barbiturates.
Absolute contraindications: Pregnancy/breastfeeding (GABA-A agonists affect fetal brain development), seizure disorders (ibotenic acid can provoke seizures), schizophrenia/psychosis, liver disease (hepatic metabolism), kidney disease (63% renal excretion), respiratory conditions.
~25% of participants in Baba Masha's study reported mild withdrawal effects (mood changes, insomnia) after stopping regular use. Taper gradually rather than stopping abruptly.
Muscimol content varies up to 10-fold between specimens (0.5-3 mg/g). Season, geography, and preparation method all affect potency. ALWAYS use a milligram scale and start with minimum doses from each new batch.
No antidote exists for muscimol/ibotenic acid poisoning. Treatment is purely supportive. Atropine and physostigmine are contraindicated despite historical misconceptions. If poisoning suspected, call emergency services immediately.
⚠️ Interactions & Combinations
Important information about drug interactions and combinations. Always consult a physician before combining.
Benzodiazepines
Synergistic GABA-A effects. Risk of profound respiratory depression, coma, and death. NEVER combine.
Alcohol
Both enhance GABA-A activity; muscimol potentiates ethanol sedation. Severe respiratory depression and death possible. NEVER combine.
Opioids
Synergistic respiratory depression. Risk of fatal respiratory failure. NEVER combine.
GHB/GBL
Combined CNS depression. Risk of respiratory failure. NEVER combine.
Barbiturates
Direct chloride channel opening combined with muscimol effects causes severe respiratory depression. NEVER combine.
Phenibut/Gabapentin/Pregabalin
GABAergic synergy leads to respiratory depression and coma risk. Avoid combination.
SSRIs/TCAs
Unpredictable effects; listed as contraindication by microdosing authors. Caution advised.
Lithium
Unknown interaction; narrow therapeutic window makes combination risky. Avoid.
MAOIs
Broad interaction potential with MAOIs. Avoid combination.
Antipsychotics
Enhanced sedation and motor impairment. Use caution.
💊 Dosage Guidelines
Typical dosage ranges from sub-perceptual microdoses to full psychoactive doses
Microdose
1.0 mg
Sub-perceptual
Threshold
5.0 mg
First noticeable effects
Moderate
10.0 mg
Full effects
Strong
15.0 mg
Intense experience
📋 Microdosing Protocols
Recommended protocols and regimens for microdosing this substance.
Baba Masha Protocol
Dosage:
- Dried Amanita: 0.5-1.0 g
- Pure Muscimol: 1-5 mg
Schedule:
Timing-dependent: morning for alertness, evening for sleep
Developed by Russian-American physician Baba Masha from findings with 3,000+ participants. Timing of dose determines effects—morning for alertness, evening for sleep improvement. ~25% of participants reported mild withdrawal effects (mood changes, insomnia).
Amanita Dreamer 3-3-3 Protocol
Schedule:
Variable frequency, decreasing over time
Developed by online educator Amanita Dreamer. Structured tapering approach to prevent tolerance and dependence.
Detailed Schedule:
- Days 1-3: Daily microdose, few hours before bedtime
- Wait 3 days
- Every 3 days for 3 weeks
- Every 5 days for 1 month
- Every 10 days (maintenance)
✨ Reported Effects
Sedation & Relaxation
Calming, sedative effect through GABA-A receptor agonism; distinct from serotonergic psychedelics
Sleep Enhancement
Improved sleep quality and depth reported at low doses; reduced sleep onset latency
Reduced Anxiety
GABAergic calming reduces stress and anxiety; mild anxiolytic effect at sub-sedative doses
Mood Modulation
Subtle mood improvements reported by some microdosers; effects are variable and dose-sensitive
Dream Enhancement
More vivid, memorable dreams and altered hypnagogic states reported at low doses
⚠️ Safety Information
Start with very low doses (1–3mg muscimol) due to significant potency variation between individual mushrooms. Never use raw or fresh Amanita muscaria — always use properly dried and ideally decarboxylated material. Do not combine with alcohol, benzodiazepines, or other CNS depressants. Effects differ significantly from psilocybin.
🔬 Scientific Research
Current research findings and clinical studies.
Rivera-Illanes D, Recabarren-Gajardo G. (2024) "Classics in Chemical Neuroscience: Muscimol." ACS Chemical Neuroscience, 15(18):3257-3269. Comprehensive review of muscimol pharmacology and history.
Ramawad HA et al. (2023) "Muscimol as a treatment for nerve injury-related neuropathic pain: a systematic review and meta-analysis." Korean Journal of Pain, 36(4):425-440. Meta-analysis of 22 preclinical studies showing significant pain reduction.
Akk G et al. (2020) "Enhancement of Muscimol Binding and Gating by Allosteric Modulators." Molecular Pharmacology, 98(4):303-313. Detailed receptor binding mechanisms.
Korpi ER et al. (2010) "Prototypic GABAA Receptor Agonist Muscimol Acts Preferentially Through Forebrain High-Affinity Binding Sites." Neuropsychopharmacology, 35(4):898-907. Demonstrates preferential activity at extrasynaptic δ-receptors.
Johnston GAR (2014) "Muscimol as an Ionotropic GABA Receptor Agonist." Neurochemical Research, 39:1942-1947. Foundational review of muscimol as GABA-A agonist.
⚖️ Legal Status
Current legal status in various jurisdictions. Always respect local laws.
| Jurisdiction | Status | Details |
|---|---|---|
| United States (Federal) |
Not scheduled, but FDA unapproved
|
Not a controlled substance federally. However, FDA declared (December 2024) that muscimol, ibotenic acid, and muscarine are unapproved food additives—products marketed for consumption are technically "adulterated." |
| Louisiana (US) |
Illegal
|
Explicitly prohibits possession/distribution with intent. 2-10 years imprisonment, up to $20,000 fine. |
| Netherlands |
Illegal
|
Banned since 2008. |
| Australia |
Schedule 9 (prohibited)
|
Prohibited substance. |
| Romania |
Illegal
|
Banned since 2010. |
| Thailand |
Category 5 drug
|
Controlled substance. |
| Canada |
Legal (NHP approved)
|
Health Canada approved Amanita as a Natural Health Product ingredient in 2021. Licensed products are legal. |
| UK |
Legal for possession
|
Legal for possession and personal use. |
| Czech Republic |
Legal
|
Legal for possession and personal use. |
| Germany |
Legal
|
Legal for possession and personal use. |
👤 Key Figures
Notable figures associated with the research and history of this substance.
R. Gordon Wasson (1898-1986)
Ethnomycologist
Investment banker turned ethnomycologist who proposed that Soma—the divine substance of the Vedas—was Amanita muscaria. His 1968 book "Soma: Divine Mushroom of Immortality" remains influential. Wasson's "three filters" theory explains traditional preparation methods.
Masahiro Takemoto
Chemist
Isolated muscimol and clarified its relationship to ibotenic acid.
Baba Masha, M.D.
Physician, microdosing researcher
Russian-American physician who published findings from the first international microdosing study involving 3,000+ participants in 2022. Her book "Microdosing with Amanita Muscaria" (foreword by James Fadiman) documented reported benefits for sleep, pain, and addiction interruption. Sparked the 2019 "Golden Amanita Fever."
Amanita Dreamer
Online educator
Online educator since 2019 who developed the "3-3-3" microdosing protocol and created the largest online Amanita information repository. Her 2023 book "Dosing Amanita Muscaria" provides practical guidance on various dosing approaches.
Giorgio Samorini
Ethnobotanist
Documented historical use of Amanita species and muscimol-containing preparations.
Graham Johnston
Neuropharmacologist
Demonstrated GABA-like actions of muscimol in 1968, establishing its mechanism as a GABA-A receptor agonist. Foundational work for understanding muscimol pharmacology.
Conrad Eugster
Chemist (University of Zurich)
Published the chemical structure of muscimol in 1967, enabling systematic pharmacological research.
Kevin Feeney, PhD, JD
Cultural anthropologist
Edited "Fly Agaric: A Compendium of History, Pharmacology, Mythology, & Exploration" (2020), the most comprehensive academic volume on Amanita muscaria.
Siberian shamanic traditions
Indigenous ceremonial practice
Use may date to 6000-4000 BCE. The Koryak people of Kamchatka believed the mushroom was a divine gift from Big Raven. The Khanty people used dried specimens for energy, pain relief, and sleep. Urine recycling practice documented across multiple Siberian cultures.
Important Legal Notice
⚠️ Personal Responsibility
You use this application entirely at your own risk and responsibility. MicrodosingDiary is only a tool for recording personal experiences.
🚫 Not a Medical Service
This application IS NOT a medical tool, does not provide medical advice, does not diagnose or treat any conditions. Always consult a qualified physician.
⚖️ Legislation and Laws
Many substances used for microdosing are illegal in many countries. Users are fully responsible for complying with local laws. The application does not support or promote illegal activity.
❌ No Guarantees
We provide no guarantees regarding results, safety or efficacy of microdosing. All information is for informational purposes only.
🔞 Age Restriction
Application is intended only for persons over 18 years of age. By using the application you confirm that you are an adult.
🔒 Data Privacy
Your data is private and encrypted. We never share it with third parties without your consent. Application is for personal use only.
By using this application you accept all the above risks and waive any claims against the application operator.